» Articles » PMID: 37196179

Exploring Animal Models in Oral Cancer Research and Clinical Intervention: A Critical Review

Overview
Journal Vet Med Sci
Date 2023 May 17
PMID 37196179
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a leading cause of death worldwide, but advances in treatment, early detection, and prevention have helped to reduce its impact. To translate cancer research findings into clinical interventions for patients, appropriate animal experimental models, particularly in oral cancer therapy, can be helpful. In vitro experiments using animal or human cells can provide insight into cancer's biochemical pathways. This review discusses the various animal models used in recent years for research and clinical intervention in oral cancer, along with their advantages and disadvantages. We highlight the advantages and limitations of the used animal models in oral cancer research and therapy by searching the terms of animal models, oral cancer, oral cancer therapy, oral cancer research, and animals to find all relevant publications during 2010-2023. Mouse models, widely used in cancer research, can help us understand protein and gene functions in vivo and molecular pathways more deeply. To induce cancer in rodents, xenografts are often used, but companion animals with spontaneous tumours are underutilized for rapid advancement in human and veterinary cancer treatments. Like humans with cancer, companion animals exhibit biological behaviour, treatment responses, and cytotoxic agent responses similar to humans. In companion animal models, disease progression is more rapid, and the animals have a shorter lifespan. Animal models allow researchers to study how immune cells interact with cancer cells and how they can be targeted specifically. Additionally, animal models have been extensively used in research on oral cancers, so researchers can use existing knowledge and tools to better understand oral cancers using animal models.

Citing Articles

Single-Cell Sequencing: Genomic and Transcriptomic Approaches in Cancer Cell Biology.

Ortega-Batista A, Jaen-Alvarado Y, Moreno-Labrador D, Gomez N, Garcia G, Guerrero E Int J Mol Sci. 2025; 26(5).

PMID: 40076700 PMC: 11901077. DOI: 10.3390/ijms26052074.


Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.

Tom V, Jose A, Mallick S, Sasidharan A, Pawar R, Somayaji Y Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40063239 DOI: 10.1007/s00210-025-03985-4.


The Effect of Collagen-Propolis-Eucalyptus Hydrogel in Wound Healing: An In Vivo Study (Rat Model).

Tahmasebi E, Yazdanian A Vet Med Sci. 2025; 11(2):e70225.

PMID: 39927901 PMC: 11809206. DOI: 10.1002/vms3.70225.


Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal disease.

Alam M, Faruk Hosen M, Ganji K, Ahmed K, Bui F J Genet Eng Biotechnol. 2024; 22(4):100431.

PMID: 39674633 PMC: 11539153. DOI: 10.1016/j.jgeb.2024.100431.


Rodent models for oral microbiome research: considerations and challenges- a mini review.

Gopinath D, Pandiar D, Li Z, Panda S Front Oral Health. 2024; 5:1439091.

PMID: 39421460 PMC: 11484444. DOI: 10.3389/froh.2024.1439091.


References
1.
Chen Y, Chang K, Yang I, Tu H, Lin S . Establishment of syngeneic murine model for oral cancer therapy. Oral Oncol. 2019; 95:194-201. DOI: 10.1016/j.oraloncology.2019.06.026. View

2.
Coppock J, Vermeer P, Vermeer D, Lee K, Miskimins W, Spanos W . mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Oncotarget. 2016; 7(17):24228-41. PMC: 5029697. DOI: 10.18632/oncotarget.8286. View

3.
Masuda H, Yamamoto N, Shibahara T . Early Detection of Leukoplakic Oral Squamous Cell Carcinoma Using 4NQO-induced Rat Tongue Cancer Model: Study Utilizing Fluorescence Intensity and Histopathological Evaluation. Bull Tokyo Dent Coll. 2022; 63(1):1-12. DOI: 10.2209/tdcpublication.2020-0014. View

4.
Porcellato I, Brachelente C, Guelfi G, Reginato A, Sforna M, Bongiovanni L . A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer. PLoS One. 2014; 9(11):e112833. PMC: 4234530. DOI: 10.1371/journal.pone.0112833. View

5.
Luo J, Young C, Zhou H, Wang X . Mouse Models for Studying Oral Cancer: Impact in the Era of Cancer Immunotherapy. J Dent Res. 2018; 97(6):683-690. PMC: 6728551. DOI: 10.1177/0022034518767635. View